The role of viral diagnostic tests in respiratory tract infections: moving forward
- PMID: 38606841
- PMCID: PMC11094630
- DOI: 10.37201/req/150.2023
The role of viral diagnostic tests in respiratory tract infections: moving forward
Abstract
The increased knowledge on virology and the increased potential of their diagnostic has risen several relevant question about the role of an early viral diagnosis and potential early treatment on the management of respiratory tract infections (RTI). In order to further understand the role of viral diagnostic tests in the management of RTI, a panel of experts was convened to discuss about their potential role, beyond what had been agreed in Influenza. The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI. Molecular Infection Viral Diagnostic (mIVD) tests should be used in all adult patients admitted to Hospital with RTI, and in paediatric patients requiring admission or who would be referred to another hospital for more specialised care. The increased use of mIVD will not only reduce the inappropriate use of antibiotics so reducing the antibiotic microbe resistance, but also will improve the outcome of the patient if an aetiologic viral therapy can be warranted, saving resource requirements and improving patient flows. Implementing IVD testing in RTI has various organizational benefits as well, but expanding its use into clinical settings would need a cost-effectiveness strategy and budget impact assessment.
El aumento del conocimiento virológico y el mayor potencial de su diagnóstico ha planteado una serie de preguntas relevantes sobre el papel de un diagnóstico viral precoz y así la posibilidad de un tratamiento precoz dirigido para el mane-jo de las infecciones del tracto respiratorio (ITR). Con el fin de comprender mejor el papel de las pruebas diagnósticas virales en el manejo de la ITR, se convocó a un panel de expertos para discutir sobre el posible uso de dicho diagnóstico vírico, más allá de lo establecido en documentos previos acordados para la gripe. El objetivo del panel fue comprender la plausibilidad del diagnóstico viral etiológico precoz en el manejo clínico; formular algunas recomendaciones sobre la posible ampliación del uso de dichas pruebas en el futuro y definir algunas lagunas en la gestión sanitaria de la ITR.
Las pruebas de diagnóstico viral de infección molecular (mIVD) deben utilizarse en todos los pacientes adultos ingresados en el hospital con ITR, y en determinados pacientes pediátricos que requieran ingreso o que sean derivados a otro hospital para recibir atención más especializada. El aumento del uso de mIVD no solo reducirá el uso inadecuado de antibióticos, reduciendo así la resistencia microbiana a los anti-bióticos, sino que también mejorará el resultado del paciente si se inicia una terapia viral etiológica, reduciendo consumo de recursos y mejorando los flujos de pacientes. Asimismo, existen beneficios organizativos en la implementación de pruebas de diagnóstico in vitro en la ITR que requerirán una estimación del impacto presupuestario y un enfoque de rentabilidad para una mayor penetración en su uso clínico.
Keywords: molecular diagnostic tests; respiratory tract infection; viral diagnostic tests.
©The Author 2024. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).
Conflict of interest statement
The authors declare no conflicts of interest
Similar articles
-
Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30707378 Free PMC article.
-
Viral respiratory tract infections diagnosis: a Spanish survey and consensus approach.Diagn Microbiol Infect Dis. 2025 Sep;113(1):116831. doi: 10.1016/j.diagmicrobio.2025.116831. Epub 2025 May 3. Diagn Microbiol Infect Dis. 2025. PMID: 40354688
-
Direct multiplexed whole genome sequencing of respiratory tract samples reveals full viral genomic information.J Clin Virol. 2015 May;66:6-11. doi: 10.1016/j.jcv.2015.02.010. Epub 2015 Feb 18. J Clin Virol. 2015. PMID: 25866327 Free PMC article.
-
Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel.Ann N Y Acad Sci. 2011 Mar;1222(1):6-13. doi: 10.1111/j.1749-6632.2011.05964.x. Ann N Y Acad Sci. 2011. PMID: 21434937 Free PMC article. Review.
-
Testing for Respiratory Viruses in Children: To Swab or Not to Swab.JAMA Pediatr. 2017 Aug 1;171(8):798-804. doi: 10.1001/jamapediatrics.2017.0786. JAMA Pediatr. 2017. PMID: 28672402 Review.
References
-
- Overview | Neonatal infection: antibiotics for prevention and treatment | Guidance | NICE [Internet]. NICE; 2021. [cited 16/03/2024]. Available at: https://www.nice.org.uk/guidance/ng195
-
- Stamm BD, Tamerius J, Reddy S, Barlow S, Hamer C, Kempken A, et al. . The Influence of Rapid Influenza Diagnostic Testing on Clinician Decision-Making for Patients With Acute Respiratory Infection in Urgent Care. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;76(11):1942-8. 10.1093/cid/ciad038 - DOI - PMC - PubMed
-
- Rapid tests for flu reduce spread of disease in hospital - NIHR Evidence. [cited 16/03/2024]. Disponible en: https://evidence.nihr.ac.uk/alert/rapid-tests-flu-meant-earlier-treatmen...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources